
Global Hemp Group Inc. — Investor Relations & Filings
Global Hemp Group Inc. focuses on two key segments: Industrial Hemp and Biopharma. The Industrial Hemp division develops innovative, green, and sustainable solutions utilizing the whole hemp plant for environmental applications, including carbon-negative construction materials, sustainable bio-energy sources, bio-composites, textiles, and nonwovens. This strategy is executed through the Hemp Agro-Industrial Zone (HAIZ) concept, which integrates raw material supply with industrial processing. The company also maintains an R&D division dedicated to developing patented IP for hemp-based eco-friendly building materials. The Biopharma division centers on acquiring exclusive licensing of advanced Intellectual Property, notably holding exclusive perpetual licenses to Apollon Formularies' proprietary technology and patents for developing cancer treatments from natural biologics (such as medical cannabis and functional mushrooms) using an AI-based drug discovery platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2025-10-09 | English | |
| News release - English.pdf | 2025-04-08 | English | |
| News release - English.pdf | 2025-03-27 | English | |
| News release - English.pdf | 2025-03-18 | English | |
| News release - English.pdf | 2025-03-13 | English | |
| News release - English.pdf | 2025-02-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
13 filings
| |||||
| 32343196 | News release - English.pdf | 2025-10-09 | English | ||
| 13784058 | News release - English.pdf | 2025-04-08 | English | ||
| 13780675 | News release - English.pdf | 2025-03-27 | English | ||
| 13777976 | News release - English.pdf | 2025-03-18 | English | ||
| 13777388 | News release - English.pdf | 2025-03-13 | English | ||
| 13771229 | News release - English.pdf | 2025-02-27 | English | ||
| 31698288 | News release - English.pdf | 2025-02-13 | English | ||
| 31642029 | News release - English.pdf | 2025-01-30 | English | ||
| 13766220 | Report of exempt distribution (45-106F1).pdf | 2025-01-28 | English | ||
| 13765230 | Material change report - English.pdf | 2025-01-20 | English | ||
| 13765424 | News release - English.pdf | 2025-01-18 | English | ||
| 13764767 | News release - English.pdf | 2025-01-11 | English | ||
| 13764325 | News release - English.pdf | 2025-01-07 | English | ||
|
2024
2 filings
| |||||
| 13762019 | News release - English.pdf | 2024-12-12 | English | ||
| 13762017 | News release - English.pdf | 2024-12-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Dermapharm Holding SE
A manufacturer of patent-free branded pharmaceuticals and h…
|
DMP | DE | Manufacturing |
|
Dermata Therapeutics, Inc.
Medical dermatology company developing and commercializing …
|
DRMA | US | Manufacturing |
|
Desh Rakshak Aushdhalaya Ltd.
Manufacturer of GMP-certified Ayurvedic and herbal medicine…
|
531521 | IN | Manufacturing |
|
Design Therapeutics, Inc.
Clinical-stage biopharma developing small molecule therapie…
|
DSGN | US | Manufacturing |
|
Deutsche Biotech Innovativ AG
Develops therapeutics for serious diseases using innovative…
|
DBI | DE | Manufacturing |
|
DEVA HOLDİNG A.Ş.
Develops, produces, and markets human medicines, APIs, and …
|
DEVA | ES | Manufacturing |
|
Devonian Health Group Inc
Clinical-stage botanical pharmaceutical company focused on …
|
GSD | CA | Manufacturing |
|
Devyser Diagnostics
Develops DNA testing kits for hereditary diseases, oncology…
|
DVYSR | SE | Manufacturing |
|
DexTech Medical AB
Develops drug candidates for urological oncology, focusing …
|
DEX | SE | Manufacturing |
|
Dezhan Healthcare Company Limited
Researches and produces cardiovascular chemical drugs and o…
|
000813 | CN | Manufacturing |
Global Hemp Group Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46553/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46553 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46553 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46553 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46553}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Global Hemp Group Inc. (id: 46553)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.